Fulcrum Therapeutics to Present at the 10th Annual BioPharm America International Partnering Conference

Fulcrum Therapeutics, a company focused on discovering and developing small molecule therapies that unlock gene regulation to treat serious genetic diseases, will present at the 10th Annual BioPharm America International Partnering Conference in Boston, Mass.

Robert Gould, Ph.D., Fulcrum’s President and Chief Executive Officer, will give a presentation in the Rare and Orphan Disease category titled “Restoring Balance in Gene Regulation” at the Sheraton Boston Hotel on September 27th at 10:45am. Read More.